Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Does increased gut Proteobacteria (Enterobacter or Citrobacter) slow gut motility via endotoxin-driven inflammation?

Higher abundance of Proteobacteria such as Enterobacter and Citrobacter increases intestinal endotoxin (LPS) and triggers TLR4-dependent inflammatory and oxidative signaling that impairs enteric neuromuscular function and slows gut motility.

PlausibleJune 19, 202623 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Increased gut abundance of Proteobacteria such as Enterobacter and Citrobacter is associated with higher lipopolysaccharide (endotoxin) burden and intestinal inflammatory/oxidative stress signaling that can impair gut motility.

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links overgrowth of Gram-negative Proteobacteria to an expanded luminal endotoxin pool that activates TLR4/NF-κB pathways, increasing ROS and pro-inflammatory cytokines. This localized inflammatory and oxidative environment promotes enteric neuropathy, loss of enteric glia, and iNOS-derived nitric oxide production, which together reduce smooth muscle contractility and prolong intestinal transit.

Verified conclusion

Mechanistic pathways of endotoxin-induced stress

  • Endotoxin expansion: Gram-negative Proteobacteria, such as Enterobacter and Citrobacter, harbor lipopolysaccharide (LPS) as a core structural component of their outer membrane. Consequently, an overgrowth or bloom of these taxa directly expands the luminal and mucosal endotoxin pool.
  • TLR4 activation and oxidative signaling: Elevated luminal LPS binds to Toll-like receptor 4 (TLR4) complexes on epithelial cells, enteric glia, and myenteric neurons. This interaction recruits downstream NF-κB signaling cascades, accelerating the generation of reactive oxygen species (ROS) and promoting the localized release of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).

Impact on gastrointestinal motility

  • Enteric neuropathy and glial loss: Chronic TLR4-mediated activation and localized oxidative stress induce enteric neuropathies and the loss of enteric glial cells. This glial and neuronal degeneration impairs the structural and signaling networks necessary for coordinate neuromuscular transmission.
  • Contractility suppression: The localized inflammatory microenvironment induces inducible nitric oxide synthase (iNOS), resulting in excessive production of nitric oxide (NO). Elevated NO acts as a potent inhibitory signal that, together with direct oxidative damage to smooth muscle cells, suppresses contractility and prolongs intestinal transit time.

Bottom line

  • Increased abundance of Proteobacteria like Enterobacter and Citrobacter elevates the intestinal endotoxin burden, initiating TLR4-dependent inflammatory and oxidative cascades. This localized signaling drives enteric neuropathy, glial loss, and iNOS activation, which collectively impair neuromuscular coordination and suppress smooth muscle contractility to slow gut motility.

References

  1. Biochemistry, Lipopolysaccharide - StatPearls - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  2. Total Lipopolysaccharide from the Human Gut Microbiome Silences ... — pmc.ncbi.nlm.nih.gov ↗
  3. Lipopolysaccharide - Wikipedia — en.wikipedia.org ↗
  4. Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and ... — pmc.ncbi.nlm.nih.gov ↗
  5. Proteobacteria: A Common Factor in Human Diseases - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Gut microbial products regulate murine gastrointestinal motility via ... — pmc.ncbi.nlm.nih.gov ↗
  7. Toll-like receptor 4–mediated enteric glia loss is critical for the ... — pure.johnshopkins.edu ↗
  8. The enteric nervous system - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  9. [PDF] TLR2 and TLR4 Modulate Mouse Ileal Motility by the Interaction with ... — zaguan.unizar.es ↗
  10. Molecular mechanisms of enteric neuropathies in high-fat diet ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  11. High‐fat diets on the enteric nervous system: Possible interactions and mechanisms underlying dysmotility — onlinelibrary.wiley.com ↗
  12. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review — link.springer.com ↗
  13. Obesity-Related Oxidative Stress and Antioxidant Properties of Natural Compounds in the Enteric Nervous System: A Literature Overview — mdpi.com ↗
  14. 5-Fluorouracil Induces Enteric Neuron Death and Glial Activation During Intestinal Mucositis via a S100B-RAGE-NFκB-Dependent Pathway — nature.com ↗
  15. Time-dependent changes in inhibitory action of lipopolysaccharide ... — pmc.ncbi.nlm.nih.gov ↗
  16. Dioscin ameliorates slow transit constipation in mice by up-regulation of the BMP2 secreted by muscularis macrophages — ijbms.mums.ac.ir ↗
  17. Structure characterization of polysaccharides from Cistanche deserticola and their neuroprotective effects against oxidative stress in slow transit constipation mice. — linkinghub.elsevier.com ↗
  18. [PDF] Toll-like receptor 4, enteric nervous system and gut neuromuscular ... — research.unipd.it ↗
  19. Shanthi Srinivasan, MD | Profile - Emory School of Medicine — med.emory.edu ↗
  20. Slow transit constipation: A functional disorder becomes an enteric ... — pmc.ncbi.nlm.nih.gov ↗
  21. Visceral neuropathy in slow transit constipation - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  22. The role of nitric oxide in small intestinal motility in a model of acute ... — digitalcommons.library.tmc.edu ↗
  23. Effects of endotoxin on regulation of intestinal smooth muscle nitric ... — sciencedirect.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→